{"nct_id":"NCT04965493","title":"A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-09-20","start_date_type":"ACTUAL","primary_completion_date":"2026-04","primary_completion_date_type":"ESTIMATED","completion_date":"2027-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}